These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3593072)

  • 21. Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective in lowering LDL, without lowering HDL cholesterol.
    Lappegård KT; Enebakk T; Thunhaug H; Hovland A
    Atherosclerosis; 2016 Aug; 251():119-123. PubMed ID: 27318831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group.
    Gordon BR; Kelsey SF; Dau PC; Gotto AM; Graham K; Illingworth DR; Isaacsohn J; Jones PH; Leitman SF; Saal SD; Stein EA; Stern TN; Troendle A; Zwiener RJ
    Am J Cardiol; 1998 Feb; 81(4):407-11. PubMed ID: 9485128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid composition of aorta of Watanabe heritable hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Plasma lipid composition determines aortic lipid composition of hypercholesterolemic rabbits.
    Rosenfeld ME; Chait A; Bierman EL; King W; Goodwin P; Walden CE; Ross R
    Arteriosclerosis; 1988; 8(4):338-47. PubMed ID: 3395270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.
    Virgolini I; Koller E; Li S; Yang Q; Banyai M; Rauscha F; Pidlich J; Pirker W; Sinzinger H
    Atherosclerosis; 1993 Sep; 102(2):217-26. PubMed ID: 8251008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Removal of apolipoprotein E-enriched high density lipoprotein by LDL-apheresis in familial hypercholesterolaemia: a possible activation of the reverse cholesterol transport system.
    Koizumi J; Inazu A; Fujita H; Takeda M; Uno Y; Kajinami K; Mabuchi H; Takeda R
    Atherosclerosis; 1988 Nov; 74(1-2):1-8. PubMed ID: 3145747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemostatic variables in homozygous familial hypercholesterolemia. Effect of regular plasma cholesterol removal by low density lipoprotein apheresis.
    Di Minno G; Cerbone AM; Cirillo F; Postiglione A; Colucci M; Semeraro N; Scarpato N; Gnasso A; Margaglione M; Gallotta G
    Arteriosclerosis; 1990; 10(6):1119-26. PubMed ID: 2123091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP.
    Julius U; Metzler W; Pietzsch J; Fassbender T; Klingel R
    Int J Artif Organs; 2002 Dec; 25(12):1180-8. PubMed ID: 12518963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemia.
    Frénais R; Maugeais C; Ouguerram K; Zaïr Y; Bard JM; Charbonnel B; Magot T; Krempf M
    Metabolism; 2001 Jun; 50(6):635-9. PubMed ID: 11398137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis.
    Donner MG; Parhofer KG; Richter WO; Schwandt P
    Metabolism; 1999 Jul; 48(7):881-6. PubMed ID: 10421230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmalogen phospholipids in plasma lipoproteins of normolipidemic donors and patients with hypercholesterolemia treated by LDL apheresis.
    Bräutigam C; Engelmann B; Reiss D; Reinhardt U; Thiery J; Richter WO; Brosche T
    Atherosclerosis; 1996 Jan; 119(1):77-88. PubMed ID: 8929259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective and semiselective low-density lipoprotein apheresis in familial hypercholesterolemia.
    Busnach G; Cappelleri A; Vaccarino V; Franceschini G; Dal Col A; Perrino ML; Brando B; Sirtori C; Minetti L
    Blood Purif; 1988; 6(3):156-61. PubMed ID: 3395475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of LDL apheresis on blood rheology in two patients with homozygous familial hypercholesterolaemia.
    Fadul JE; Sandhagen B; Linde T; Vessby B; Wikström B; Danielson BG
    Blood Purif; 1997; 15(3):182-7. PubMed ID: 9262844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermediate density lipoprotein cholesterol as the best lipoprotein predictor of atherosclerosis severity in the Watanabe Heritable Hyperlipidemic rabbit.
    Nordestgaard BG; Agerholm-Larsen B; Mortensen A; Fischer Hansen B; Fischer Hansen J; Ibsen P; Kjeldsen K
    Atherosclerosis; 1997 Jul; 132(1):119-22. PubMed ID: 9247367
    [No Abstract]   [Full Text] [Related]  

  • 34. Selective continuous removal of low density lipoproteins by dextran sulfate cellulose column adsorption apheresis in the therapy of familial hypercholesterolemia.
    Stefanutti C; Isacchi GC; Antonini R; Bucci A; Cardillo A; Di Nucci GD; Gozzer M; Malagnino F; Masci M; Mazzarella B
    Beitr Infusionsther; 1988; 23():172-82. PubMed ID: 2484773
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein e4.
    Moriarty PM; Luyendyk JP; Gibson CA; Backes JM
    Am J Cardiol; 2010 Jun; 105(11):1585-7. PubMed ID: 20494666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma exchange treatment for severe familial hypercholesterolemia: a comparison of two different techniques.
    Dairou F; Rottembourg J; Truffert J; Assogba U; Bruckert E; de Gennes JL; Jacobs C
    Beitr Infusionsther; 1988; 23():152-9. PubMed ID: 2484771
    [No Abstract]   [Full Text] [Related]  

  • 38. Alterations in the HDL system after rapid plasma cholesterol reduction by LDL-apheresis.
    Franceschini G; Apebe P; Calabresi L; Busnach G; Minetti L; Vaccarino V; Sirtori CR
    Metabolism; 1988 Aug; 37(8):752-7. PubMed ID: 3405092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral blood flow velocity and systemic vascular resistance after acute reduction of low-density lipoprotein in familial hypercholesterolemia.
    Rubba P; Faccenda F; Di Somma S; Gnasso A; Scarpato N; Iannuzzi A; Nappi G; Postiglione A; De Divitiis O; Mancini M
    Stroke; 1993 Aug; 24(8):1154-61. PubMed ID: 8342189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of LDL-apheresis on the pharmacokinetics of the lipophilic antilipidemic agent probucol.
    Komura T; Takahara K; Sugano M; Fujinishi A; Tasaki H; Nakashima Y; Kuroiwa A
    Eur J Drug Metab Pharmacokinet; 1997; 22(3):201-6. PubMed ID: 9358199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.